Developmental Research Program
Developmental Research Program
批准号:
10226975
负责人:
David B Solit
金额:
$15.65万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-24 至 2023-07-31
关键词:
AddressAdvocateAnimalsAreaCancer BiologyClinicalCommunitiesComplementDevelopmentDiagnosisDoctor of PhilosophyEarly DiagnosisEtiologyFacultyFundingGenerationsGoalsGrowthHumanIndividualInstitutionInternationalInterventionInvestigator-Initiated ResearchKnowledgeLeadershipLifeMalignant NeoplasmsMalignant neoplasm of urinary bladderMemorial Sloan-Kettering Cancer CenterPatientsPeer ReviewPelvisPilot ProjectsPoliciesPreventionProceduresPrognosisPublic HealthRenal carcinomaRequest for ProposalsResearchResearch PersonnelResearch Project GrantsSeedsTestingTranslational ResearchUnderrepresented MinorityUnited StatesUniversitiesUreter CarcinomaUrotheliumWomanbasebladder Carcinomacareerinnovationmedical schoolsmemberpreferenceprogramssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The goal of the Developmental Research Program (DRP) of the SPORE in Bladder Cancer at Memorial Sloan
Kettering Cancer Center (MSK) is to support innovative translational research projects in urothelial cancer by
establishing mechanisms for rapid funding. Developmental Research Program funds in the SPORE in Bladder
Cancer, supplemented by institutional funds, will allow us to support projects by new and established
investigators that are critical to the generation of new ideas in the prevention, diagnosis, and treatment of
urothelial cancer. We will request proposals for urothelial cancer pilot projects with translational potential from
clinical and basic investigators within the larger MSK community, including Rockefeller University and Weill
Cornell Medical College. After rigorous peer review by the DRP Directors, Internal and External Advisory
Boards, and the Patient Advocate, the most promising new projects from this wide portfolio of developmental
research projects will be selected. Preference will be given to projects that complement the long-term research
goals of the SPORE and advance our translational research objectives. The DRP may also solicit and fund
experimental or clinical initiatives that address an urgent and specific need in the MSK SPORE in Bladder
Cancer program or a unique research opportunity. Eligible pilot project applicants to the DRP must have an
MD, MD/PhD, or PhD degree in a relevant area of research, be appointed as faculty members at MSK or
affiliated institution (Weill Cornell Medical College, Rockefeller University), demonstrate commitment to an
academic career in translational research related to urothelial cancer, and agree to participate in all relevant
conferences and activities related to the MSK SPORE in Bladder Cancer for the duration of support. The DRP
is committed to adhering to and supporting the MSK policies and procedures to promote diversity and
strengthen the participation of women and individuals from underrepresented minorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomics Core
-
批准号:10495181
-
项目类别:
-
资助金额:$51.43万
-
财政年份:2019
-
负责人:David B Solit
-
依托单位:
Genomics Core
-
批准号:10003309
-
项目类别:
-
资助金额:$52.11万
-
财政年份:2019
-
负责人:David B Solit
-
依托单位:
Genomics Core
-
批准号:10708058
-
项目类别:
-
资助金额:$51.43万
-
财政年份:2019
-
负责人:David B Solit
-
依托单位:
Genomics Core
-
批准号:9792984
-
项目类别:
-
资助金额:$54.1万
-
财政年份:2019
-
负责人:David B Solit
-
依托单位:
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
-
批准号:10475013
-
项目类别:
-
资助金额:$45.26万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
-
批准号:9979814
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
Developmental Research Program
-
批准号:10453637
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations
-
批准号:10438820
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
-
批准号:10218077
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
-
批准号:10226969
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
Developmental Research Program
-
批准号:9979826
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
-
批准号:10453632
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2018
-
负责人:David B Solit
-
依托单位:
Defining the temporal sequence of PI3K pathway mutations in bladder cancer
-
批准号:8620150
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:David B Solit
-
依托单位:
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
-
批准号:7766925
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2008
-
负责人:David B Solit
-
依托单位:
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
-
批准号:7582332
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2008
-
负责人:David B Solit
-
依托单位:
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
-
批准号:7466269
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2008
-
负责人:David B Solit
-
依托单位:
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
-
批准号:8016108
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2008
-
负责人:David B Solit
-
依托单位:
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
-
批准号:8230767
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2008
-
负责人:David B Solit
-
依托单位:
Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer
-
批准号:10707961
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2001
-
负责人:David B Solit
-
依托单位:
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
-
批准号:9571349
-
项目类别:
-
资助金额:$40.74万
-
财政年份:--
-
负责人:David B Solit
-
依托单位:
海外基金